There comes a time every once in a cycle when the market gets too invested in either a bullish or bearish view, and just like ...

On December 8, Bob Doll, Crossmark Global Investments CEO and CIO, joined CNBC’s ‘Squawk on the Street’ to discuss the latest market trends and his expectations for the Fed. Doll believes that the ...

Last week, several high short-interest, momentum-driven stocks broke out strongly, riding the wave of speculation as the ...

With 23% of its float short, Viking Therapeutics has been gaining momentum. In fact, since bottoming out at around $25, it’s now up to $38.88. With a short interest of 24.5%, Altimmune is another ...

JPMorgan Chase (NYSE: JPM) will kick off peak fiscal 2025 Q4 reporting on Jan. 13, 2026, which means there is not much time left to position for the season. The takeaway in early December is that many ...

Beyond Meat stock soared back in October as a group of traders on social media stock briefly sent the stock up more than ...

If you’ve been trading for at least the last few years, you’ve experienced some wild trends. One of the most prevalent has been “the short squeeze” trend. Thanks to companies now considered meme ...

The short interest on 30 out of 37 consumer staple stocks—part of the Consumer Staples Select Sector SPDR Fund (NYSEARCA:XLP)—rose in November vs. the previous month, while short interest for the ...

Shares of Hims & Hers Health Inc. (NYSE: HIMS) have been the hottest thing in the medical sector, and for good reason. The company's fundamentals are highly attractive for investors who prefer to ...

Short interest can help investors gauge sentiment. Not only can high short interest identify potential high risks, it can also be a sign of a possible short squeeze situation – especially if the stock ...

Fueling Viking Therapeutics upside, analysts at Canaccord initiated coverage of the obesity treatment stock with a buy rating, and a price target of $106 a share With a short interest of 25%, Lemonade ...